Altcoins News
By Steven Anderson
1 / 15
Nasdaq Moves To Suspend Trading. In a filing with the U.S. Securities and Exchange Commission (SEC) on Tuesday, Windtree (trading…
2 / 15
The BNB Treasury Bet. Windtree Therapeutics had briefly captured investor attention last month when it revealed a BNB…
3 / 15
Additional Financing Deals Raise Questions. In late July, Windtree followed up with further reveals , including a $500 million equity line of…
4 / 15
CEO Vows Continued Disclosures. Despite the Nasdaq suspension, Windtree’s CEO, Jed Latkin, confirmed that the company would…
5 / 15
Biotech Meets Crypto: A Risky Experiment. Windtree’s experiment with a BNB treasury reflects a broader wave of publicly listed companies…
6 / 15
BNB Soars Despite Windtree’s Woes. Interestingly, the delisting news did not dampen BNB’s own performance. On Wednesday, BNB surged 5.
7 / 15
What’s Next for Windtree?. With its Nasdaq listing set to be suspended, Windtree now faces the prospect of trading OTC, where…
8 / 15
Windtree Therapeutics, a Pennsylvania-based biotech company that made headlines in July for adopting a Binance Coin (BNB) treasury strategy, suffered a massive 77% stock price…
9 / 15
The sharp decline marks one of the steepest single-day drops for a Nasdaq-listed biotech this year and underscores the risks facing smaller firms experimenting with…
10 / 15
In a filing with the U.S. Securities and Exchange Commission (SEC) on Tuesday, Windtree (trading under ticker WINT) confirmed it had received a noncompliance notice from Nasdaq.
11 / 15
Windtree’s shares have consistently traded below that threshold since mid-July, with Wednesday’s collapse pushing them down another 77.2% to $0.11 per share.
12 / 15
Nasdaq will officially suspend Windtree’s trading on Thursday. While delisting does not dissolve a company, it severely limits its access to capital markets and investor…
13 / 15
The move was part of a growing trend among smaller public companies to add exposure to cryptocurrencies in their balance sheet.
14 / 15
Initially, the reveal gave WINT shares a short-lived boost, climbing 32% in two days. However, optimism quickly faded.
15 / 15
In late July, Windtree followed up with further reveals , including a $500 million equity line of credit with an unnamed institutional investor, alongside a $20 million…
The Currency Analytics
Want the full story?